Shen Xueyong, Zhao Ling, Ding Guanghong, Tan Ming, Gao Jianping, Wang Lizhen, Lao Lixing
Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai, 201203, China.
Lasers Med Sci. 2009 Mar;24(2):129-36. doi: 10.1007/s10103-007-0536-9. Epub 2008 Jan 5.
Our objective was to assess the efficacy and safety of combined 10.6 microm and 650 nm laser irradiation on patients with knee osteoarthritis (OA). Forty patients with OA were randomly allocated to an active laser group or to a placebo laser group (20 per group). They either received active or sham laser treatment at acupoint Dubi (ST 35) in a total of 12 sessions. There was significant difference between the two groups in the Western Ontario and McMaster Universities (WOMAC) osteoarthritis index pain score change from baseline after 2 weeks of treatment (P = 0.047). The pain reduction of the active laser treatment group was 49%, whereas that of the placebo control group was only 13%. However, due to the high patient drop-out rate, the 4-week assessment could not be analyzed. Combined laser treatment seems beneficial to patients with knee OA. However, due to the small sample size and the high drop-out rate of patients in the placebo group, a large sample-size clinical trial is warranted to determine further the therapeutic efficacy of the device.
我们的目的是评估10.6微米和650纳米激光联合照射对膝骨关节炎(OA)患者的疗效和安全性。40例OA患者被随机分为活性激光组或安慰剂激光组(每组20例)。他们在犊鼻穴(ST 35)接受活性或假激光治疗,共12次。治疗2周后,两组在西安大略和麦克马斯特大学(WOMAC)骨关节炎指数疼痛评分相对于基线的变化方面存在显著差异(P = 0.047)。活性激光治疗组的疼痛减轻了49%,而安慰剂对照组仅为13%。然而,由于患者脱落率高,无法对4周评估进行分析。联合激光治疗似乎对膝OA患者有益。然而,由于样本量小和安慰剂组患者脱落率高,有必要进行大样本量的临床试验以进一步确定该设备的治疗效果。